نتایج جستجو برای: hodgkin lymphomas

تعداد نتایج: 37471  

Journal: :Archives of Pathology & Laboratory Medicine 2015

2017
Dolores Caballero Umberto Vitolo Martin Dreyling Roch Houot

Disclosure: Prof Caballero has served as a member of advisory boards and participated in educational activities for Bristol-Myers Squibb, Celgene, Janssen, Kite, Nordic, and Roche. Prof Vitolo has received research grants and served as principal investigator in studies sponsored by Celgene and Roche; he received sponsorship for speaking engagements at conferences and educational activities from...

Journal: :International Journal of Cancer 2012

Journal: :Asian Pacific journal of cancer prevention : APJCP 2013
Joo Y Song Jianbo Yu Wing C Chan

Although the current WHO classification (Swerdlow et al. WHO classification of tumours of haematopoietic and lymphoid tissues. International Agency for Research on Cancer, Lyon, 2008 [1]) for hematolymphoid neoplasms has delineated lymphomas based on the combined morphologic, immunophenotypic, and genotypic findings, further refinement is necessary especially in regard to therapeutics and progn...

Journal: :Cancer control : journal of the Moffitt Cancer Center 2012
Michael Tomblyn

BACKGROUND Radioimmunotherapy (RIT) is a safe and effective therapeutic option for patients with indolent B-cell non-Hodgkin lymphomas (NHL), in both up-front and relapsed/refractory settings. Two approved agents (90Y-ibritumomab tiuxetan and 131I-tositumomab) are available in the United States. Both target CD20 with similar clinical outcomes but with unique clinical considerations and radiatio...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید